Tao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tao Xu has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Haiyong Yu
Molecular Synthesis Center & Key Laboratory of Marine Drugs, Ministry of Education; School of Medicine and Pharmacy
7 shared publicationsJianyu Zhang
Molecular Synthesis Center & Key Laboratory of Marine Drugs Ministry of Education; School of Medicine and Pharmacy Laboratory for Marine Drugs and Bioproducts of Marine Natural Products Ocean University of China 5 Yushan road Qingdao 266003 China
6 shared publicationsLingfei Hu
6 shared publicationsXi Wang
5 shared publicationsDongxu Ma
4 shared publicationsQingxing Yang
Molecular Synthesis Center & Key Laboratory of Marine Drugs, Ministry of Education; School of Medicine and Pharmacy
4 shared publications
Latest Publications
- 15 September 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (38) , 12022-12026
Direct Pyridine Dearomatization via Organocatalytic Enantioselective [4 + 2] Cycloaddition Accessing Polyfused Aza-[2.2.2] Scaffolds
Herein, we report the first chiral phosphoric-acid-catalyzed asymmetric [4 + 2] dearomatization of monocyclic pyridines. Distinct from previous activation modes, this transformation proceeds under purely thermal conditions and does not require external irradiation or photoredox catalysis. Readily accessible nicotinic acid derivatives undergo efficient intramolecular [4 + 2] cycloaddition to furnish polyfused aza-bicyclo[2.2.2]octane frameworks with high levels of enantiocontrol. This work addresses the longstanding challenge associated with the functionalization of monocyclic pyridines and represents the first example of an asymmetric [4 + 2]-cycloaddition-based dearomatization of pyridines.
- 15 September 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (38) , 12022-12026
Direct Pyridine Dearomatization via Organocatalytic Enantioselective [4 + 2] Cycloaddition Accessing Polyfused Aza-[2.2.2] Scaffolds
Herein, we report the first chiral phosphoric-acid-catalyzed asymmetric [4 + 2] dearomatization of monocyclic pyridines. Distinct from previous activation modes, this transformation proceeds under purely thermal conditions and does not require external irradiation or photoredox catalysis. Readily accessible nicotinic acid derivatives undergo efficient intramolecular [4 + 2] cycloaddition to furnish polyfused aza-bicyclo[2.2.2]octane frameworks with high levels of enantiocontrol. This work addresses the longstanding challenge associated with the functionalization of monocyclic pyridines and represents the first example of an asymmetric [4 + 2]-cycloaddition-based dearomatization of pyridines.
- 23 December 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (1) , 584-589
Copper-Catalyzed Enantioselective [1,3] O-to-C Rearrangement of Heteroaryl Alkyl Ethers
Herein, we extend a catalytic enantioselective dearomative [1,3] O-to-C rearrangement constructing C2 quaternary benzofuranones/3-oxindoles from readily accessible C3-heteroaryl alkyl ethers. The abundant Cu(II) salts with (S,S)-BOX were used as catalysts. The reaction features a broad scope (over 30 examples) with good yields (up to 99%) and enantioselectivity (up to 99% ee). Control experiments revealed that the [1,3] rearrangement proceeded via zwitterionic intermediates. Additionally, compound 2w was discovered to be selectively enriched in lipid-rich tissues of zebrafish and display blue fluorescence emission, suggesting potential applications as a new chemical.
- 23 December 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (1) , 584-589
Copper-Catalyzed Enantioselective [1,3] O-to-C Rearrangement of Heteroaryl Alkyl Ethers
Herein, we extend a catalytic enantioselective dearomative [1,3] O-to-C rearrangement constructing C2 quaternary benzofuranones/3-oxindoles from readily accessible C3-heteroaryl alkyl ethers. The abundant Cu(II) salts with (S,S)-BOX were used as catalysts. The reaction features a broad scope (over 30 examples) with good yields (up to 99%) and enantioselectivity (up to 99% ee). Control experiments revealed that the [1,3] rearrangement proceeded via zwitterionic intermediates. Additionally, compound 2w was discovered to be selectively enriched in lipid-rich tissues of zebrafish and display blue fluorescence emission, suggesting potential applications as a new chemical.
- 29 August 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
Asymmetric Total Synthesis of (−)-Psychotriadine Featuring [3,3]-Rearrangement and Stereo-Controllable Ring-Contraction
The first asymmetric total syntheses of (-)-psychotriadine (1) and its putative congener tetrahydropsychotriadine (2) were accomplished in 12 and 13 steps, respectively, featuring Meerwein-Eschenmoser-Claisen rearrangement and Fischer indolization/Plancher rearrangement cascade. A stereochemically controllable dearomative ring contraction was utilized to create the vicinal quaternary stereocenters. The absolute configuration was confirmed through X-ray crystallography and >200 mg of 1 (90% enantiomeric excess (ee)) was obtained. Biological studies revealed that natural product precursor S-10 acts as an agonist toward liver X receptors (LXRs, KD = 1.22/0.79 μM), which upregulates protein levels of ABCA1 and APOE, exhibiting potential as a drug lead in developing medicine for Alzheimer's disease.
- 29 August 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
Asymmetric Total Synthesis of (−)-Psychotriadine Featuring [3,3]-Rearrangement and Stereo-Controllable Ring-Contraction
The first asymmetric total syntheses of (-)-psychotriadine (1) and its putative congener tetrahydropsychotriadine (2) were accomplished in 12 and 13 steps, respectively, featuring Meerwein-Eschenmoser-Claisen rearrangement and Fischer indolization/Plancher rearrangement cascade. A stereochemically controllable dearomative ring contraction was utilized to create the vicinal quaternary stereocenters. The absolute configuration was confirmed through X-ray crystallography and >200 mg of 1 (90% enantiomeric excess (ee)) was obtained. Biological studies revealed that natural product precursor S-10 acts as an agonist toward liver X receptors (LXRs, KD = 1.22/0.79 μM), which upregulates protein levels of ABCA1 and APOE, exhibiting potential as a drug lead in developing medicine for Alzheimer's disease.
- 24 June 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (3)
Retro aza-[2+2] cycloaddition as stereochemical editing logic for multi-substituted azacyclobutanes
- 24 June 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (3)
Retro aza-[2+2] cycloaddition as stereochemical editing logic for multi-substituted azacyclobutanes
- 1 January 2025
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 45 (3) , 764
Total Syntheses of Marine-Derived Polyhalogenated Natural Products
- 1 January 2025
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 45 (3) , 764
Total Syntheses of Marine-Derived Polyhalogenated Natural Products
- 3 June 2024
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (12) , 9207-9216
Organocatalytic Highly Enantioselective Formal [1,3] Sigmatropic Rearrangement of Indole Alkyl Ethers and Mechanistic Insight
- 3 June 2024
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (12) , 9207-9216
Organocatalytic Highly Enantioselective Formal [1,3] Sigmatropic Rearrangement of Indole Alkyl Ethers and Mechanistic Insight
- 29 May 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (28) , e202405838
Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand
Transition‐metal‐catalyzed [4+4] cycloaddition leading to cyclooctanoids has centered on dimerization between 1,3‐diene‐type substrates. Herein, we describe a [4σ+4π−1] and [4σ+4π] cycloaddition strategy to access 7/8‐membered fused carbocycles through rhodium‐catalyzed coupling between the 4σ‐donor (benzocyclobutenones) and pendant diene (4π) motifs. The two pathways can be controlled by adjusting the solvated CO concentration. A broad range (>40 examples) of 5–6–7 and 5–6–8 polyfused carbocycles was obtained in good yields (up to 90 %). DFT calculations, kinetic monitoring and 13C‐labeling experiments were carried out, suggesting a plausible mechanism. Notably, one 5–6–7 tricycle was found to be a very rare, potent, and selective ligand for the liver X receptor β (KD=0.64 μM), which is a potential therapeutic target for cholesterol‐metabolism‐related fatal diseases.
- 29 May 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (28) , e202405838
Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand
Transition‐metal‐catalyzed [4+4] cycloaddition leading to cyclooctanoids has centered on dimerization between 1,3‐diene‐type substrates. Herein, we describe a [4σ+4π−1] and [4σ+4π] cycloaddition strategy to access 7/8‐membered fused carbocycles through rhodium‐catalyzed coupling between the 4σ‐donor (benzocyclobutenones) and pendant diene (4π) motifs. The two pathways can be controlled by adjusting the solvated CO concentration. A broad range (>40 examples) of 5–6–7 and 5–6–8 polyfused carbocycles was obtained in good yields (up to 90 %). DFT calculations, kinetic monitoring and 13C‐labeling experiments were carried out, suggesting a plausible mechanism. Notably, one 5–6–7 tricycle was found to be a very rare, potent, and selective ligand for the liver X receptor β (KD=0.64 μM), which is a potential therapeutic target for cholesterol‐metabolism‐related fatal diseases.
- 29 May 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (28) , e202405838
Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand
Transition‐metal‐catalyzed [4+4] cycloaddition leading to cyclooctanoids has centered on dimerization between 1,3‐diene‐type substrates. Herein, we describe a [4σ+4π−1] and [4σ+4π] cycloaddition strategy to access 7/8‐membered fused carbocycles through rhodium‐catalyzed coupling between the 4σ‐donor (benzocyclobutenones) and pendant diene (4π) motifs. The two pathways can be controlled by adjusting the solvated CO concentration. A broad range (>40 examples) of 5–6–7 and 5–6–8 polyfused carbocycles was obtained in good yields (up to 90 %). DFT calculations, kinetic monitoring and 13C‐labeling experiments were carried out, suggesting a plausible mechanism. Notably, one 5–6–7 tricycle was found to be a very rare, potent, and selective ligand for the liver X receptor β (KD=0.64 μM), which is a potential therapeutic target for cholesterol‐metabolism‐related fatal diseases.
- 29 May 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (28) , e202405838
Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand
Transition‐metal‐catalyzed [4+4] cycloaddition leading to cyclooctanoids has centered on dimerization between 1,3‐diene‐type substrates. Herein, we describe a [4σ+4π−1] and [4σ+4π] cycloaddition strategy to access 7/8‐membered fused carbocycles through rhodium‐catalyzed coupling between the 4σ‐donor (benzocyclobutenones) and pendant diene (4π) motifs. The two pathways can be controlled by adjusting the solvated CO concentration. A broad range (>40 examples) of 5–6–7 and 5–6–8 polyfused carbocycles was obtained in good yields (up to 90 %). DFT calculations, kinetic monitoring and 13C‐labeling experiments were carried out, suggesting a plausible mechanism. Notably, one 5–6–7 tricycle was found to be a very rare, potent, and selective ligand for the liver X receptor β (KD=0.64 μM), which is a potential therapeutic target for cholesterol‐metabolism‐related fatal diseases.
- 1 January 2024
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 44 (11) , 3564-3565
Synthesis of Bridged Five-Membered Ring Systems by Type II [3+2] Annulation of Allenylsilane-Ene
- 1 January 2024
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 44 (11) , 3564-3565
Synthesis of Bridged Five-Membered Ring Systems by Type II [3+2] Annulation of Allenylsilane-Ene
- 4 October 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (41) , 22335-22340
Enantioselective Total Syntheses of (−)-Caulamidine D and (−)-Isocaulamidine D and Their Absolute Configuration Reassignment
The first enantioselective total syntheses of (-)-caulamidine D (5) and (-)-isocaulamidine D (6) were accomplished. Their absolute configurations were unambiguously elucidated through X-ray crystallography. The isolated natural samples of both 5 and 6 are determined to be the TFA salts instead of the neutral forms. It took 16 steps (longest linear sequence) to divergently access both 5 and 6 following a unified strategy. The key reactions include (1) development and application of an asymmetric Meerwein-Eschenmoser-Claisen rearrangement to construct the challenging C10, C23 consecutive stereocenters and (2) application of a cascade 6-exo-dig/6-exo-tet amine/nitrile cyclization reaction.
- 4 October 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (41) , 22335-22340
Enantioselective Total Syntheses of (−)-Caulamidine D and (−)-Isocaulamidine D and Their Absolute Configuration Reassignment
The first enantioselective total syntheses of (-)-caulamidine D (5) and (-)-isocaulamidine D (6) were accomplished. Their absolute configurations were unambiguously elucidated through X-ray crystallography. The isolated natural samples of both 5 and 6 are determined to be the TFA salts instead of the neutral forms. It took 16 steps (longest linear sequence) to divergently access both 5 and 6 following a unified strategy. The key reactions include (1) development and application of an asymmetric Meerwein-Eschenmoser-Claisen rearrangement to construct the challenging C10, C23 consecutive stereocenters and (2) application of a cascade 6-exo-dig/6-exo-tet amine/nitrile cyclization reaction.